Literature DB >> 17350634

Separation of amino acids, peptides and corresponding Amadori compounds on a silica column at elevated temperature.

Zhigang Hao1, Chih-Ying Joey Lu, Baiming Xiao, Naidong Weng, Barry Parker, Michael Knapp, Chi-Tang Ho.   

Abstract

Maillard reaction of glucose with amino acids and peptides has become a very important experimental model in the food flavor and pharmaceutical industries for better understanding the mechanism of food flavor generation and drug stability. Because of the amino acid and sugar functional groups present in their structures, most of the reaction components formed during the initial stages of Maillard reaction as well as the substrates are relatively polar. These compounds are poorly retained on a conventional reversed phase column. While polar stationary phases like HILIC column do provide better retention for these polar components, method selectivity could still be a challenge due to the structural similarity between these analytes. In this report, parameters such as pH, mobile phase composition and temperature were investigated using different brands of bare silica columns in order to separate glycine (G), diglycine (DG), triglycine (TG), and the corresponding Amadori compounds of glucose-glycine (GG), glucose-diglycine (GDG) and glucose-triglycine (GTG). An excellent separation for glycine, glycine peptides and their Amadori compounds was obtained on a bare silica column at an elevated temperature.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350634     DOI: 10.1016/j.chroma.2007.02.057

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

Review 1.  Hydrophilic interaction liquid chromatography (HILIC)--a powerful separation technique.

Authors:  Bogusław Buszewski; Sylwia Noga
Journal:  Anal Bioanal Chem       Date:  2011-08-31       Impact factor: 4.142

2.  An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma.

Authors:  Jianmei Wu; Nader Sanai; Xun Bao; Patricia LoRusso; Jing Li
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-06-03       Impact factor: 3.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.